Editorial Board About Us

European Randomized Study of Screening for Prostate Cancer(ERSPC)

All articles from this key word are listed below.

Volume 11, Number 3 Review Articles

Screening for Prostate Cancer: A Review of the ERSPC and PLCO Trials

Management Update

Herbert Lepor Samir S Taneja Bob Djavan Elisabeth Eckersberger Julia Finkelstein Helen Sadri Markus Margreiter

The advent of prostate-specific antigen (PSA) testing in the early 1980srevolutionized the diagnosis of prostate cancer. As a result of PSA testing,there has been a surge in the number of prostate cancer diagnoses. Thisreview examines the results of 2 recent landmark trials that studied the effectof screening on prostate cancer mortality: the European Randomized Study ofScreening for Prostate Cancer (ERSPC) and the US-based Prostate, Lung,Colorectal, and Ovarian (PLCO) Cancer Screening Trial.[Rev Urol. 2009;11(3):127-133 doi: 10.3909/riu0474]

PSA screening European Randomized Study of Screening for Prostate Cancer(ERSPC)Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial